Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalamine for T cell activation in HIV
NCT01090102Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Jun 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Salcrozine in human immunodeficiency virus infection (HIV), sponsored by University of California, San Francisco. Started Jun 2010; status: completed.
02
Drugs
Salcrozine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01090102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01090102.